Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 245

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 245
---
000 sold to the February
Buyers. The form of these promissory notes is included as Exhibit 4.2 of the Form 6-K filed on April 4, 2024. The aforementioned Securities
Purchase Agreement is included as Exhibit 4.1 of the Form 6-K filed on April 4, 2024.

On August 7, 2024, the Company
entered into a Securities Purchase Agreement (“Securities Purchase Agreement”) with certain investors named therein (collectively,
the “Buyers”), pursuant to which, amongst other things: (i) the Company agreed to sell, at an initial closing (and such initial
closing, the “Initial Closing”), (a) a senior convertible note (the “Initial Note”) in the aggregate original
principal amount not exceeding $1,100,000, convertible into Class A Ordinary Shares pursuant to its terms, (b) a warrant to purchase 1,325,301
Class A Ordinary Shares (such warrant, the “Series A Warrant” and prior to any Reverse Stock Splits), and (c) a warrant to
purchase 180,722 Class A Ordinary Shares (the “Series B Warrant” and prior to any Reverse Stock Splits); and (ii) the Company
may require each Buyer (or each Buyer may require the Company, as applicable) to participate in the sale of (a) one or more additional
convertible notes (which aggregate original principal amount for all additional convertible notes shall not exceed $9,500,000) (the “Additional
Notes”) and (b) related Warrants.

<div align='center'>II-1</div>

The Securities Purchase Agreement
is filed as Exhibit 4.1 of the Company’s current report on Form 6-K dated August 16, 2024 and is incorporated by reference herein.
The Initial Note is filed as Exhibit 10.25 of this registration statement.

Additionally, in connection
with the Securities Purchase Agreement, the Company entered into amendment and exchange agreements with certain holders of its convertible
promissory notes (the “Existing Notes” and each of such amendment and exchange agreements, an “Amendment and Exchange
Agreement”), pursuant to which the Company exchanged the Existing Notes by issuing, among other things, (i) senior convertible notes
in the aggregate principal amount of $2,700,000 (the “Exchange Notes”, and, together with the Initial Note and the Additional
Notes, the “Notes”) and (b